Anticoagulation management in primary care: a trial-based economic evaluation

This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Primary care provided similar levels of control to secondary care for patients on anticoagulation therapy. There was an increased cost of treating patients in primary care, and at no point did primary care become a lower cost option than secondary care. Local decision-makers need to assess the increased cost of anticoagulation management in primary care, in terms of the potential reductions in high-cost serious adverse events.